Aimmune Therapeu Shares Up 7.2% Since SmarTrend's Buy Recommendation (AIMT)

SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on September 11th, 2019 at $24.73. In approximately 2 months, Aimmune Therapeu has returned 7.24% as of today's recent price of...